Literature DB >> 29476883

Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea.

J-H Hwang1, J S Park2, E Lee3, J Y Bae3, K-H Song4, P G Choe3, W B Park3, J H Bang3, E S Kim4, S W Park3, N J Kim3, M Oh3, H B Kim5.   

Abstract

A 10-month active surveillance study was conducted to assess carriage of carbapenemase-producing Enterobacteriaceae (CPE), vancomycin-resistant enterococci (VRE) and toxigenic Clostridium difficile colonization among patients transferred to hospital from long-term care facilities (LTCFs). Four (1.4%) patients with carbapenem-resistant Enterobacteriaceae (none of which were CPE), 59 (21%) patients with VRE and 20 (7.1%) patients colonized with toxigenic C. difficile were identified from 282 rectal specimens. There was no outbreak of VRE infection during the study period. The low prevalence of CPE carriage suggests that screening all admissions from LTCFs for CPE would not be cost-effective, and that screening and use of contact precautions for VRE should be reconsidered.
Copyright © 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Active surveillance; Carbapenem-resistant Enterobacteriaceae; Carbapenemase-producing Enterobacteriaceae; Toxigenic Clostridium difficile; Vancomycin-resistant enterococci

Mesh:

Year:  2018        PMID: 29476883     DOI: 10.1016/j.jhin.2018.02.017

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

Review 1.  Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.

Authors:  Hsin-Yu Chen; Shio-Shin Jean; Yu-Lin Lee; Min-Chi Lu; Wen-Chien Ko; Po-Yu Liu; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

2.  Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.

Authors:  Jung-Wan Park; Hyungmin Lee; Se Yoon Park; Tae Hyong Kim
Journal:  Antimicrob Resist Infect Control       Date:  2019-03-05       Impact factor: 4.887

3.  Prevalence and Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study.

Authors:  Jin Suk Kang; Jongyoun Yi; Mee Kyung Ko; Soon Ok Lee; Jeong Eun Lee; Kye Hyung Kim
Journal:  J Korean Med Sci       Date:  2019-05-13       Impact factor: 2.153

4.  Active Surveillance for Carbapenem-resistant Enterobacteriaceae at a Single Center for Four Years.

Authors:  Inho Choi; Yangsoon Lee
Journal:  Ann Lab Med       Date:  2022-05-01       Impact factor: 3.464

5.  Positivity of Carbapenemase-producing Enterobacteriaceae in Patients Following Exposure within Long-term Care Facilities in Seoul, Korea.

Authors:  Jin Ju Park; Yu Bin Seo; Jacob Lee; Joong Sik Eom; Wonkeun Song; Young Kyun Choi; Sung Ran Kim; Hee Jung Son; Nan Hyoung Cho
Journal:  J Korean Med Sci       Date:  2020-09-14       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.